The Water Problem: Why Hydroquinone, Tretinoin and Hydrocortisone Last Longer in an Anhydrous Gel
Hydroquinone and tretinoin are two of the fussier ingredients we compound. They don't like water, they don't like light, and they don't like sitting around. That's most of the reason we offer this combination in PCCA's PermE8 and WO6 gels, and it's also why the date on the label deserves a closer read.
Dermatology gels are compounded to a prescriber's specified strengths and base in the non sterile lab at Mixwell Compounding Pharmacy in Chino, CA.
What this combination is
Hydroquinone, tretinoin and hydrocortisone is a three ingredient topical that pairs a skin lightening agent, a retinoid and a mild corticosteroid, and prescribers use versions of it in the management of melasma and other hyperpigmentation. The corticosteroid is there partly to calm the irritation the other two can cause.
It follows the same idea as Tri-Luma, the FDA approved cream that combines hydroquinone and tretinoin with a different steroid, fluocinolone acetonide. Ours isn't that product. The steroid is hydrocortisone, which is milder, and the strength of every ingredient is whatever the prescriber writes.
That difference matters for the evidence. The version with the most published behind it is the fluocinolone one, and a 2025 meta analysis of Kligman's formula calls it the most studied formulation. Kligman's original recipe used higher strengths and a stronger steroid, and the modern versions built on a low potency steroid are generally described as easier to tolerate. A hydrocortisone version has less published behind it, so we don't claim it behaves the same way.
Where Tri-Luma fits the patient, it's generally the appropriate first choice. The reason to compound is a difference that matters for that patient, such as a different steroid, a different strength or a different base, and that reason belongs on the prescription.
What the 2026 consensus papers say
Two recent expert consensus papers agree that daily sun protection is essential and that hydroquinone based triple combination cream is the leading topical option under supervision, but the global consensus says it should not be used for maintenance.
The international Delphi consensus, published in the Journal of the European Academy of Dermatology and Venereology, gathered 40 dermatologists from 11 countries. They called broad spectrum sunscreen with UVA, UVB and visible light coverage essential, and described supervised use of hydroquinone based triple combination as the gold standard topical. A separate global consensus on melanin pigment disorders agreed on the first part and added that maintenance is needed to prevent relapse, with hydroquinone based triple combination avoided for that stage.
We go through both papers in more detail in our guide to compounded melasma cream and the PermE8 and WO6 bases.
Why water is the problem
Hydroquinone breaks down by oxidation, and PCCA notes that oxidation is a concern when it is compounded in water containing bases, which is why PCCA built WO6 to hold ingredients like it.
Tretinoin is touchy in its own way. It's sensitive to light and to oxidation, which is why it comes in tight, light resistant containers. So the base and the jar both matter.
A cream adds one more problem. Water means the preparation has to stay preserved against microbial growth, and that's a big part of why water containing preparations get short default dates under USP 795. Take most of the free water out and both the chemistry and the microbiology get easier to manage. Our guide to anhydrous compounding bases explains water activity in plain terms.
What anhydrous does to the date
A gel in an anhydrous base such as WO6 or PermE8 has water activity below 0.6, which gives it a USP 795 default beyond use date of up to 180 days, while a water containing cream defaults to 14 or 35 days.
| Feature | Water containing cream | Anhydrous gel in WO6 or PermE8 |
|---|---|---|
| Water activity | 0.6 or above | Below 0.6 |
| USP 795 default date | 14 days if not preserved, 35 days if preserved | Up to 180 days |
| Storage | Follow the label. Oxidation is a concern for hydroquinone in water containing bases. | PCCA states WO6 preparations with hydroquinone can be kept at room temperature when no aqueous ingredients are added. |
| Fills for a multi month plan | Usually more than one | Often one |
| Feel | Familiar cream | Smooth gel, described by PCCA as not greasy or tacky |
Defaults apply when no USP monograph or preparation specific stability data exists. The date can't exceed the shortest expiration of any component, and adding an aqueous ingredient can move the preparation into a shorter category.
Here's what that looks like in practice. Say a prescriber plans a couple of months of treatment. In a water containing cream with a 35 day date, that's at least two fills, each one compounded and shipped separately. In the anhydrous gel it can often go out in one. Fewer fills means fewer shipments and fewer chances for a patient to run out in between. Our guide to how bases set beyond use dates goes through the rules.
A longer date is not a longer course
A 180 day beyond use date is the last day the preparation can be used, not a treatment length, and for this combination that difference matters.
Tri-Luma is labeled for short term treatment of moderate to severe facial melasma, with sun avoidance measures including sunscreen, and it isn't indicated for maintenance. Its label also warns that hydroquinone can cause exogenous ochronosis and that this should prompt stopping treatment. The global consensus likewise advises against hydroquinone based triple combination for maintenance.
So we ask prescribers to write the quantity for the course they actually intend. The longer date buys convenience and a margin of stability. It doesn't buy extra months of use.
Match the quantity per fill to the plan you intend, and let your reassessment schedule decide how long the gel continues, not the date on the jar.
PermE8 or WO6
PermE8 and WO6 are both PCCA anhydrous gel bases with water activity below 0.6, and each is built for a slightly different job. Here's what PCCA reports about each.
WO6 Anhydrous Topical Gel
Topical • DermatologyPCCA describes WO6 as a smooth, creamy anhydrous gel for dermatologic and cosmetic use. It can hold ingredients that are unstable in water, and it leaves no greasy or tacky residue. PCCA states that hydroquinone preparations in WO6 can be stored at room temperature when no aqueous ingredients are added, and it lists azelaic acid, hydroquinone and tretinoin among WO6's common actives.
PCCA specifies WO6 for topical use only and recommends EMP jars for dispensing.
PermE8 Anhydrous Gel
Topical • Permeation enhancingPCCA describes PermE8 as a permeation enhancing anhydrous gel that can hold several actives at once, including actives in salt form. Its product booklet lists hydrocortisone, hydroquinone, fluocinolone acetonide and tretinoin among the common actives for PermE8, with dermatology among its uses.
In PCCA's in vitro testing, PermE8 delivered ketoprofen comparably to Lipoderm and at roughly four times the level of Anhydrous Lipoderm.
PCCA's literature also lists dermatology gels made in WO6 alone and in a combination of PermE8 and WO6. Which arrangement suits a prescription depends on the strengths involved and on the feel the patient will actually use every night.
The published delivery comparison used ketoprofen, so it says nothing about how much hydroquinone, tretinoin or hydrocortisone crosses skin from either base. It's laboratory data on a vehicle, not a clinical result. We're also not aware of a published clinical comparison of PermE8 and WO6 in melasma, and nothing here claims that one outperforms the other.
Want to talk through base options for a hydroquinone prescription?
Call (909) 378-7301When a cream is the better choice
A cream is a reasonable choice for patients who prefer the feel of one, and the tradeoff is a shorter beyond use date and closer attention to storage.
Some patients simply like a cream better, and some prescribers have a base they trust. We make both. Our hydroquinone, tretinoin and hydrocortisone cream page and our four ingredient gel page describe each one. A shorter date means smaller fills, so a longer plan means more of them.
Safety information
Hydroquinone carries the biggest risk in this combination, including a permanent discoloration called ochronosis, so a defined plan and follow up matter.
FDA has received reports of serious problems from skin lightening products containing hydroquinone, including rashes, facial swelling and discoloration that may be permanent, a condition called ochronosis. FDA laboratory testing has also found high levels of mercury in certain skin lightening products, and FDA states that there are no FDA approved or legally marketed over the counter skin lightening products. A patient who stops a prescribed preparation shouldn't substitute an unregulated product bought online or imported.
Tretinoin labeling advises minimizing sun exposure and using sunscreen and protective clothing, warns of severe irritation on eczematous skin, and notes there are no adequate, well controlled studies in pregnant women. Even a mild steroid can cause local effects such as skin thinning with prolonged use. Hydrocortisone labeling is for external use and directs avoiding the eyes. Daily broad spectrum sunscreen is part of the plan, not an extra. No FDA labeling describes how much of each ingredient is absorbed from a compounded gel. Tell your prescriber about allergies, and about pregnancy or breastfeeding, before starting. This list isn't complete.
What compounding adds and what it does not
Compounding can set the strength of each ingredient, choose the steroid and use an anhydrous base for a longer default date, but it can't make an unapproved combination approved or show that it outperforms an approved one.
What compounding can do
- Set the strength of each ingredient
- Choose a milder steroid than the approved product uses
- Use an anhydrous base for a longer default date
- Leave out a dye or fragrance, where the formulation allows
What it does not mean
- That the preparation is FDA approved
- That it is the same as Tri-Luma
- That it works better than an approved product
- That a long beyond use date is a long course
One regulatory point is worth knowing. Under section 503A, compounding a copy of a commercially available product is restricted unless the prescriber documents a significant difference for that patient. A different steroid or strength can be that difference, and writing the reason on the prescription is good practice.
Writing the prescription
List each ingredient with its strength, name the base and the dosage form, and match the quantity per fill to the course you intend. Those details answer most of our questions before we have to ask them.
- Write hydroquinone, tretinoin and hydrocortisone each with its strength, and mark the dosage form as a gel or a cream.
- Name the base, such as WO6, PermE8 or a PermE8 and WO6 combination, or write pharmacist's choice and we'll tell you which we used.
- State the quantity per fill and the refills, matched to the course you intend and the beyond use date.
- Note the clinical reason if the preparation differs from a commercial product, plus any allergy and pregnancy or breastfeeding status.
- Call (909) 378-7301 to confirm the formulation and the date it carries.
For the basics, see our prescriber's guide to writing compounded prescriptions, and our melasma and hyperpigmentation support page for the clinical side.
Serving prescribers in California
Mixwell Compounding Pharmacy is a PCCA member pharmacy in Chino, CA, performing non sterile compounding only. We work with dermatology and primary care prescribers across the Inland Empire, Los Angeles County and Orange County, and deliver across California.
- Chino
- Chino Hills
- Ontario
- Rancho Cucamonga
- Upland
- Pomona
- Diamond Bar
- Corona
- Riverside
- Eastvale
- Brea
- Fullerton
Common questions
What is hydroquinone, tretinoin and hydrocortisone topical?
It is a compounded three ingredient topical that pairs hydroquinone, a skin lightening agent, with tretinoin, a retinoid, and hydrocortisone, a mild corticosteroid. Prescribers use versions of it in the management of melasma and other hyperpigmentation. The strength of each ingredient is set by the prescriber.
Is it FDA approved?
No. Compounded preparations are not FDA approved. The FDA approved option is Tri-Luma, which combines hydroquinone and tretinoin with a different steroid, fluocinolone acetonide, and is labeled for short term treatment of moderate to severe facial melasma. A hydrocortisone version is a different preparation with less published evidence.
Why compound it in an anhydrous base?
Hydroquinone is prone to oxidation, and PCCA notes that oxidation is a concern when it is compounded in water containing bases. PCCA states that its WO6 base, with water activity below 0.6, can accommodate hydroquinone and that WO6 preparations of it can be stored at room temperature when no aqueous ingredients are added.
How long does an anhydrous gel last compared with a cream?
Under USP 795, a nonaqueous gel with water activity below 0.6 can carry a default beyond use date of up to 180 days, while a water containing cream defaults to 14 days if not preserved or 35 days if preserved. The date can never exceed the shortest expiration of any component.
Does a 180 day beyond use date mean I should use it for 180 days?
No. The date is the last day the preparation can be used, not a course length. The approved triple combination is labeled for short term use, and the global consensus advises against hydroquinone based triple combination for maintenance. Your prescriber sets the duration.
What is the difference between PermE8 and WO6?
Both are PCCA anhydrous gel bases with water activity below 0.6. PCCA describes PermE8 as a permeation enhancing base that can hold several actives, including salts, and WO6 as a smooth, elegant base for topical use. PCCA lists dermatology gels in WO6 and in a PermE8 and WO6 combination.
Is a cream a worse option than a gel?
No. A cream is a reasonable choice for patients who prefer the feel. The tradeoff is a shorter beyond use date, which means smaller fills, and closer attention to storage for hydroquinone.
Can I buy hydroquinone over the counter in the United States?
No. Since September 23, 2020, over the counter hydroquinone products have not been legally marketed under the CARES Act. Hydroquinone remains available by prescription, including through compounding pharmacies.
Does Mixwell accept insurance, and can I use an HSA or FSA?
Mixwell does not accept insurance. Compounded medications for people can generally be charged to an HSA or FSA account. Call (909) 378-7301 for pricing.
Key Takeaways
- This combination uses hydrocortisone, a mild steroid, where Tri-Luma uses fluocinolone, so it is a different preparation and the best evidence belongs to the fluocinolone version.
- Hydroquinone is prone to oxidation in water containing bases and tretinoin is sensitive to light and oxidation, which is why both the base and the container matter.
- An anhydrous gel in WO6 or PermE8 can carry a USP 795 default beyond use date of up to 180 days, against 14 or 35 days for a water containing cream.
- A longer date means fewer fills, not a longer course, since the approved triple combination is labeled for short term use and consensus advises against it for maintenance.
- Compounded preparations are not FDA approved, and the clinical reason for any difference from a commercial product belongs on the prescription.
Sources
- Sarkar R, et al. Delphi consensus on melasma management by international experts and Pigmentary Disorders Society. Journal of the European Academy of Dermatology and Venereology. 2026;40(4):680-692. doi:10.1111/jdv.70066
- Passeron T, et al. Global consensus on the management of melanin hyperpigmentation disorders. Journal of the European Academy of Dermatology and Venereology. 2026. PMC13109754
- Efficacy and safety of Kligman's formula in the treatment of melasma: a systematic review and meta analysis. 2025.
- Efficacy and safety of a novel triple combination cream compared to Kligman's trio for melasma. Journal of the European Academy of Dermatology and Venereology. doi:10.1111/jdv.19455
- Topical treatments for melasma and their mechanism of action. Journal of Clinical and Aesthetic Dermatology. jcadonline.com
- Tri-Luma (fluocinolone acetonide, hydroquinone, tretinoin) cream prescribing information. DailyMed. dailymed.nlm.nih.gov
- Retin-A (tretinoin) cream and gel prescribing information. DailyMed. dailymed.nlm.nih.gov
- Hydrocortisone cream 1% drug facts label. DailyMed. dailymed.nlm.nih.gov
- U.S. Food and Drug Administration. FDA works to protect consumers from potentially harmful OTC skin lightening products. fda.gov
- U.S. Food and Drug Administration. FDA warns consumers of skin products containing mercury and/or hydroquinone. fda.gov
- PCCA. WO6 Anhydrous Topical Gel product information and frequently asked questions. pccarx.com
- PCCA. Exclusive PCCA bases booklet, including PermE8 and WO6 common actives. pccarx.com
- United States Pharmacopeia. General Chapter 795, Pharmaceutical Compounding, Nonsterile Preparations, Table 4. Official November 1, 2023.
- U.S. Food and Drug Administration. Compounding and the FD&C Act, Section 503A.